Skip to main content
Fig. 2 | Journal of Biomedical Science

Fig. 2

From: The human C-type lectin 18 is a potential biomarker in patients with chronic hepatitis B virus infection

Fig. 2

Cumulative incidence of HBeAg loss and seroconversion in the patients with CHB by (a) CLEC18 and (b) HBsAg levels. Curves of cumulative rates of HBeAg loss and HBeAg seroconversion derived from Kaplan-Meier analysis stratified by (a) baseline plasma CLEC18 levels and (b) baseline HBsAg levels. Differences between cumulative incidence curves were tested using the log-rank test

Back to article page